Agile therapeutics reports second quarter 2023 financial results and provides corporate update

Twirla delivers second quarter 2023 net revenue of $5.5 million, a 44% increase from first quarter 2023 twirla demand and factory sales up 24% and 42% respectively in second quarter 2023 compared to first quarter 2023 gross margin grows to 58% in second quarter 2023 from 47% in first quarter 2023 company reaffirms expected full year 2023 net revenue in range of $25-$30 million management to host conference call today, wednesday, august 9, 2023 at 8:30 a.m. et princeton, n.j.
AGRX Ratings Summary
AGRX Quant Ranking